O abandono do hábito de fumar reduz as complicações apresentadas por pacientes e o risco de recorrência da doença.[213]Ryan WR, Allan RN, Yamamoto T, et al. Crohn's disease patients who quit smoking have a reduced risk of reoperation for recurrence. Am J Surg. 2004 Feb;187(2):219-25.
http://www.ncbi.nlm.nih.gov/pubmed/14769308?tool=bestpractice.com
[214]Nunes T, Etchevers MJ, García-Sánchez V, et al. Impact of smoking cessation on the clinical course of Crohn's disease under current therapeutic algorithms: a multicenter prospective study. Am J Gastroenterol. 2016 Mar;111(3):411-9.
http://www.ncbi.nlm.nih.gov/pubmed/26856753?tool=bestpractice.com
[215]Veauthier B, Hornecker JR. Crohn's disease: diagnosis and management. Am Fam Physician. 2018 Dec 1;98(11):661-9.
https://www.aafp.org/pubs/afp/issues/2018/1201/p661.html
http://www.ncbi.nlm.nih.gov/pubmed/30485038?tool=bestpractice.com
[216]To N, Gracie DJ, Ford AC. Systematic review with meta-analysis: the adverse effects of tobacco smoking on the natural history of Crohn's disease. Aliment Pharmacol Ther. 2016 Mar;43(5):549-61.
https://eprints.whiterose.ac.uk/97320
http://www.ncbi.nlm.nih.gov/pubmed/26749371?tool=bestpractice.com
Consulte Abandono do hábito de fumar.
Embora não haja consenso sobre as diretrizes para rastreamento de câncer colorretal em pacientes com DC, é amplamente aceito realizar colonoscopia de vigilância a cada 1-2 anos, começando 8 anos depois do estabelecimento do diagnóstico de pancolite e após 15 anos, no caso de colite no lado esquerdo.[305]Farraye FA, Odze RD, Eaden J, et al. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010 Feb;138(2):738-45.
http://www.gastrojournal.org/article/S0016-5085(09)02202-1/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/20141808?tool=bestpractice.com
[ 
]
How does surveillance compare with no surveillance for detecting colon cancer in people with ulcerative colitis or inflammatory bowel disease?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.1965/fullMostre-me a resposta A European Crohn's and Colitis Organisation recomenda que todos os pacientes com doença inflamatória intestinal sejam submetidos à colonoscopia de rastreamento 8 anos após a percepção dos sintomas iniciais, a fim de compreender, avaliar a extensão da doença e descartar a displasia.[290]Gordon H, Biancone L, Fiorino G, et al. ECCO guidelines on inflammatory bowel disease and malignancies. J Crohns Colitis. 2023 Jun 16;17(6):827-54.
https://academic.oup.com/ecco-jcc/article/17/6/827/6931718